Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsAspirus Arise Part B Injectable Prior Auth | OpenP…
    Ask Trek AI about this page
    CurrentAspirus ArisePolicy N/A

    Medical Injectable Drug (Part B) Authorization List

    Customize your policy alerts

    Sign up for all Aspirus Arise policy alerts

    Know when Aspirus Arise releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    A payer-maintained list of injectable drugs (Medicare Part B) that typically require prior authorization or step therapy before administration in outpatient/office settings; intended for providers submitting authorization requests to Aspirus Arise/Care Continuum.

    Policy Summary
    PayerAspirus Arise
    PolicyMedical Injectable Drug (Part B) Authorization List
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateN/A
    Last ReviewApr 1, 2026
    Next Review DateN/A
    Key ActionSubmit an authorization request via the OnePA Portal, by fax to Care Continuum at 1-877-266-1871, or by calling Care Continuum at 1-800-818-6747.
    SourceLink

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    ~400+injectable drugs and related HCPCS codes listed
    1submission portal listed
    fax & phoneother submission methods
    04/01/2026document update date

    Coverage Rules and Scope

    General coverage rule

    Covered when administrative requirements are met.

    Authorization/Listing requirement: Drug is on the Medical Injectable Drug (Part B) Authorization List

    Drugs on this list typically require prior authorization or step therapy via the medical benefit before administration.

    Drugs not found on this list do not require a prior authorization through the medical benefit. The general coverage rule is that a drug is covered when administrative requirements are met; drugs included on the Medical Injectable Drug (Part B) Authorization List typically require prior authorization or step therapy approval before administration.

    HCPCS / Coding List

    Partial HCPCS list (document contains an extended list across chunks)HCPCS
    Q2055Abecma
    J9264Abraxane
    J3262Actemra
    J0801Acthar Gel
    J0791Adakveo
    J9042Adcetris
    J9029Adstiladrin
    J7171Adzynma
    J1931Aldurazyme
    J9057Aliqopa
    1–10 of 17
    1/2
    All other HCPCS codes listed by drug in documentHCPCS
    No codes listed

    What Providers Must Do

    Prior Authorization

    Prior authorization required for listed Part B injectables

    Drugs listed require prior authorization or step therapy approval through the medical benefit before administration; drugs not found on this list do not require a prior authorization through the medical benefit.

    Step Therapy

    Step therapy may apply — check policy first

    Some drugs on the list may require step therapy approval; providers should review the injectable drug policy prior to submitting an approval request.

    Documentation Required

    How to submit an authorization request

    Policy Context

    This document is an administrative authorization list identifying which medical injectable drugs (Medicare Part B) are subject to prior authorization or step therapy when administered in outpatient/office settings. The drugs on this list are most often given in the doctor's office and they require either prior authorization or step therapy approval before they can be dispensed or administered. Providers should review the injectable drug policy prior to submitting an approval request and follow the listed submission methods (OnePA Portal, fax, or phone).

    Key Definitions

    Medical Injectable Drug (Part B) — definition and site of administration
    DefinitionMedical Injectable Drug (Part B): Medical drugs on this list are most often given in the doctor's office and require prior authorization or step therapy approval before they can be dispensed or given.
    Typical site of administrationDoctor's office (outpatient/office setting) — these are medical benefit (Part B) injectable drugs most often given in the office.
    Authorization requirementRequire prior authorization or step therapy approval through the medical benefit before administration.
    Not on listDrugs not found on this list do not require a prior authorization through the medical benefit.

    Where These Drugs Are Administered

    Note

    Office-administered Part B injectables require prior authorization

    These are medical benefit (Part B) injectable drugs most often given in the doctor's office; prior authorization must be obtained before administration in outpatient/office settings.

    Policy Summary
    PayerAspirus Arise
    PolicyMedical Injectable Drug (Part B) Authorization List
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateN/A
    Last ReviewApr 1, 2026
    Next Review DateN/A
    Key ActionSubmit an authorization request via the OnePA Portal, by fax to Care Continuum at 1-877-266-1871, or by calling Care Continuum at 1-800-818-6747.
    SourceLink
    On This Page
    Coverage Rules and ScopeHCPCS / Coding ListWhat Providers Must DoPolicy ContextKey DefinitionsWhere These Drugs Are Administered

    Submit an authorization request via the OnePA Portal (online ePA), fax the authorization request form to Care Continuum at 1-877-266-1871, or call Care Continuum at 1-800-818-6747.

    • Online (ePA) via the OnePA Portal
    • Fax to Care Continuum: 1-877-266-1871
    • Call Care Continuum: 1-800-818-6747
    Denial Risk

    Authorization required — failure to obtain may trigger denial

    Drugs on this list require either prior authorization or step therapy approval before they can be dispensed or given; failure to submit an authorization may result in denial.